Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration.

AIM This study aims to assess whether epigenetic changes may account for high-density lipoprotein cholesterol (HDL-C) level variability in familial hypercholesterolemia (FH), a recognized human model to study cardiovascular disease risk modulators. MATERIALS & METHODS A genome-wide DNA methylation analysis (Infinium HumanMethylation27 BeadChip, Illumina) was performed on peripheral blood DNA samples obtained from men with FH with low (n = 10) or high (n = 11) HDL-C concentrations. The initial association with one of the top differentially methylated loci located in the promoter of the TNNT1 gene was replicated in a cohort of 276 FH subjects using pyrosequencing. RESULTS According to the Ingenuity Pathway Analysis software, the HDL-C differentially methylated loci identified were significantly associated with pathways related to lipid metabolism and cardiovascular disease. TNNT1 DNA methylation levels were positively correlated with mean HDL particle size, HDL-phospholipid, HDL-apolipoprotein AI, HDL-C and TNNT1 expression levels. CONCLUSION These results suggest that epigenome-wide changes account for interindividual variations in HDL particle metabolism and that TNNT1 is a new candidate gene for dyslipidemia.

[1]  B. Turner,et al.  Defining an epigenetic code , 2007, Nature Cell Biology.

[2]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[3]  C. Bouchard,et al.  LIPE C-60G influences the effects of physical activity on body fat and plasma lipid concentrations: the Quebec Family Study , 2009, Human Genomics.

[4]  K. Clément,et al.  Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity , 1995 .

[5]  D. Hommes,et al.  Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway , 2011, Gut.

[6]  C. Marsit,et al.  Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders , 2011, Epigenetics.

[7]  D. Couper,et al.  Cyclooxygenase Polymorphisms and Risk of Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Study , 2008, Clinical pharmacology and therapeutics.

[8]  A. Bélisle,et al.  DPP4 Gene DNA Methylation in the Omentum is Associated With Its Gene Expression and Plasma Lipid Profile in Severe Obesity , 2011, Obesity.

[9]  S. Humphries,et al.  APOE/C1/C4/C2 Gene Cluster Genotypes, Haplotypes and Lipid Levels in Prospective Coronary Heart Disease Risk Among UK Healthy Men , 2010, Molecular medicine.

[10]  Inês Barroso,et al.  Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Suzanne Cheng,et al.  Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia , 2005, European Journal of Human Genetics.

[12]  K. Ueda,et al.  Liver X Receptor β (LXRβ) Interacts Directly with ATP-binding Cassette A1 (ABCA1) to Promote High Density Lipoprotein Formation during Acute Cholesterol Accumulation* , 2011, The Journal of Biological Chemistry.

[13]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[14]  Stephan Beck,et al.  Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus , 2010, BMC Medical Genomics.

[15]  D. Gaudet,et al.  Procedure to protect confidentiality of familial data in community genetics and genomic research , 1999, Clinical genetics.

[16]  R. Murray,et al.  Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder , 2011, Human molecular genetics.

[17]  G. Mcclearn,et al.  Genetic and environmental influences on serum lipid levels in twins. , 1993, The New England journal of medicine.

[18]  Min-Seon Kim,et al.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.

[19]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[20]  E. Sijbrands,et al.  The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients , 2004, Journal of internal medicine.

[21]  D. Gaudet,et al.  Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[22]  C. Becker,et al.  New universal primers facilitate Pyrosequencing™ , 2006, Electrophoresis.

[23]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[24]  J. Després,et al.  Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians. , 1998, The American journal of cardiology.

[25]  Christian Gieger,et al.  Genetic architecture of circulating lipid levels , 2011, European Journal of Human Genetics.

[26]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[27]  Jonathan C. Cohen,et al.  Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.

[28]  G. Kimura,et al.  Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. , 2007, International journal of molecular medicine.

[29]  Chan-na Zhang,et al.  Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: a meta-analysis. , 2009, Atherosclerosis.

[30]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Päivi Pajukanta,et al.  Genetic causes of high and low serum HDL-cholesterol , 2010, Journal of Lipid Research.

[32]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[33]  S Henikoff,et al.  Exploring and explaining epigenetic effects. , 1997, Trends in genetics : TIG.

[34]  J. Kastelein,et al.  Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands. , 2010, Atherosclerosis.

[35]  K. Marshall,et al.  Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. , 2007, Atherosclerosis.

[36]  A. Sharrett,et al.  Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Circulation.

[37]  A. Soutar,et al.  Mechanisms of Disease: genetic causes of familial hypercholesterolemia , 2007, Nature Clinical Practice Cardiovascular Medicine.

[38]  D. Gaudet,et al.  ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia , 2012, Epigenetics.

[39]  R. Hegele.  Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. , 2002, Atherosclerosis. Supplements.

[40]  Manuel A. R. Ferreira,et al.  Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits , 2011, BMC Medical Genetics.

[41]  G. Dagenais,et al.  Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. , 1996, Atherosclerosis.

[42]  K. Heidenreich,et al.  FoxO1 Regulates Multiple Metabolic Pathways in the Liver , 2006, Journal of Biological Chemistry.

[43]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[44]  H. Putter,et al.  Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. , 2012, International journal of epidemiology.

[45]  Massimo Gennarelli,et al.  Assignment of the slow troponin T (TNNT1) gene to chromosome 19 using polymerase chain reaction , 1992, Human Genetics.

[46]  Wei Wu,et al.  Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells , 2004, Cancer Research.

[47]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[48]  S. Tevosian,et al.  Cardiac Expression of Tnnt1 Requires the GATA4-FOG2 Transcription Complex , 2009, TheScientificWorldJournal.

[49]  B. Gellersen,et al.  Human prolactin gene expression: positive correlation between site-specific methylation and gene activity in a set of human lymphoid cell lines. , 1990, Molecular endocrinology.

[50]  D. Salem,et al.  Prevalence of risk factors in men with premature coronary artery disease. , 1991, The American journal of cardiology.

[51]  F. Marchetti,et al.  The expression of Troponin T1 gene is induced by ketamine in adult mouse brain , 2007, Brain Research.

[52]  L. Baum,et al.  Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and β3‐adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes—an 8‐year prospective cohort analysis of 1297 patients , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[53]  Luigi Bouchard,et al.  Leptin Gene Epigenetic Adaptation to Impaired Glucose Metabolism During Pregnancy , 2010, Diabetes Care.

[54]  Defesche.  World health organisation report on familial hypercholesterolemia , 2001, Atherosclerosis.

[55]  A. Scanu,et al.  HDL: bridging past and present with a look at the future , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  D. Rader,et al.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008. , 2009, Journal of Lipid Research.

[57]  Doron Lancet,et al.  Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification , 2005, Bioinform..

[58]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[59]  J. Genest,et al.  Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. , 1997, The Canadian journal of cardiology.

[60]  P. Vokonas,et al.  Ischemic Heart Disease and Stroke in Relation to Blood DNA Methylation , 2010, Epidemiology.

[61]  J. Després,et al.  Association of heterozygous familial hypercholesterolemia with smaller HDL particle size. , 2007, Atherosclerosis.

[62]  Danbo Wang,et al.  DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis , 2012, European Journal of Medical Research.

[63]  J. Després,et al.  Geographic distribution of French‐Canadian low‐density lipoprotein receptor gene mutations in the Province of Quebec , 1997, Clinical genetics.

[64]  T. Down,et al.  Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure , 2010, PloS one.

[65]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[66]  Suzanne Cheng,et al.  Genetic Determinants of Cardiovascular Disease Risk in Familial Hypercholesterolemia , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[67]  F. Offredi,et al.  Expression and functional properties of four slow skeletal troponin T isoforms in rat muscles. , 2005, American journal of physiology. Cell physiology.

[68]  A. Soutar,et al.  Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families. , 2001, Atherosclerosis.

[69]  K. Ishihara,et al.  Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. , 2000, Journal of biochemistry.